Suchergebnisse - "Carlo-Stella, Carmelo"

PubPharm (258)

11

Baseline circulating tumour DNA and interim PET predict response in relapsed/refractory classical Hodgkin lymphoma

enthalten in: British Journal of Haematology | 2024

von Calabretta, E. | Trani, M. | Corrado, F. | +10

12

In relapsed or refractory diffuse large B‐cell lymphoma, CD19 expression by immunohistochemistry alone is not a predictor of response to loncastuximab tesirine

enthalten in: eJHaem | 2024

von Caimi, P. | Hamadani, M. | Carlo‐Stella, C. | +10

13

Role of bridging RT in relapsed/refractory diffuse large B-cell lymphoma undergoing CAR-T therapy: a multicenter study

enthalten in: ResearchSquare.com | 2023

von Mannina, D. | Bramanti, S. | Chiappella, A. | +11

14

Nebivolol versus placebo in patients undergoing anthracyclines (CONTROL Trial) : rationale and study design

enthalten in: Journal of cardiovascular medicine (Hagerstown, Md.) | 2023

von Cannata, F. | Stefanini, G. | Carlo-Stella, C. | +18

15

Nivolumab combined with brentuximab vedotin for relapsed/refractory mediastinal gray zone lymphoma

enthalten in: Blood | 2023

von Santoro, A. | Moskowitz, A. | Ferrari, S. | +6

CommentIn: Blood. 2023 Jun 1;141(22):2673-2674. - PMID 37261857

16

Tumor microenvironment contribution to checkpoint blockade therapy : lessons learned from Hodgkin lymphoma

enthalten in: Blood | 2023

von Carbone, A. | Gloghini, A. | Carlo-Stella, C.

17

Isatuximab in combination with cemiplimab in patients with relapsed/refractory multiple myeloma : A phase 1/2 study

enthalten in: Cancer medicine | 2023

von Lesokhin, A. | LeBlanc, R. | Dimopoulos, M. | +18

18

Explainable domain transfer of distant supervised cancer subtyping model via imaging-based rules extraction

enthalten in: Artificial intelligence in medicine | 2023

von Cavinato, L. | Gozzi, N. | Sollini, M. | +5

19

Impact of the Extremities Positioning on the Set-Up Reproducibility for the Total Marrow Irradiation Treatment

enthalten in: Current oncology (Toronto, Ont.) | 2023

von Lambri, N. | Antonetti, S. | Dei, D. | +16

20

BET inhibitor trotabresib in heavily pretreated patients with solid tumors and diffuse large B-cell lymphomas

enthalten in: Nature communications | 2023

von Moreno, V. | Vieito, M. | Sepulveda, J. | +18